References
- Barbosa IG, Morato IB, de Miranda AS, et al. A preliminary report of increased plasma levels of IL-33 in bipolar disorder: further evidence of pro-inflammatory status. J Affect Disord. 2014;157:41–44.
- Rosenblant JD, Brietzke E, Mansur RB, et al. Inflammation as a neurobiological substrate of cognitive impairment in bipolar disorder: evidence, pathophysiology and treatment implications. J Affect Disord. 2015;1:149–159.
- Rosenblat JD, Cha DS, Mansur RB, et al. Inflamed moods: a review of the interactions between inflammation and mood disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2014;53:23–34.
- Barbosa IG, Bauer ME, Machado-Vieira R, et al. Cytokines in bipolar disorder: paving the way for neuroprogression. Neural Plast. 2014;2014:360481.
- Amirhossein M, Shervin T, Elisa B, et al. Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies. Biol Psychiatry. 2013;74:15–25.
- Cunha AB, Andreazza AC, Gomes FA, et al. Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder. Eur Arch Psychiatry Clin Neurosc. 2008;258:300–304.
- Munkholm K, Braüner JV, Kessing LV, et al. Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis. J Psychiatr Res. 2013;47:1119–1133.
- Drexhage RC, Hoogenboezem TH, Versnel MA, et al. The activation of monocyte and T cell networks in patients with bipolar disorder. Brain Behav Immun. 2011;25:1206–1213.
- Bauer IE, Pascoe MC, Wollenhaupt-Aguiar B, et al. Inflammatory mediators of cognitive impairment in bipolar disorder. J Psychiatr Res. 2014;56:18–27.
- Rolstad S, Jakobsson J, Sellgren C, et al. CSF neuroinflammatory biomarkers in bipolar disorder are associated with cognitive impairment. Eur Neuropsychopharmacol. 2015;25:1091–1098.
- Stertz L, Magalhaes PV, Kapczinski F. Is bipolar disorder an inflammatory condition? The relevance of microglial activation. Curr Opin Psychiatry. 2013;26:19–26.
- Arslan FC, Tiryaki A, Karagüzel EO, et al. Levels of ınterleukin 18, interleukin 6 and cognition in bipolar disorder. 8th International Congress on Psychopharmacology and the 4th International Symposium on Child and Adolescent Psychopharmacology; Oral presentation, 20-24 Nisan; 2016.
- Zahorec R. Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy. 2001;102:5–14.
- Balta S, Ozturk C. The platelet-lymphocyte ratio: a simple, inexpensive andrapid prognostic marker for cardiovascular events. Platelets. 2015;26:680–681.
- Kalelioglu T, Akkus M, Karamustafalioglu N, et al. Neutrophil-lymphocyte and platelet lymphocyte ratios as inflammation markers for bipolardisorder. Psychiatry Res. 2015;228:925–927.
- Azab B, Jaglall N, Atallah JP, et al. Neutrophil-lymphocyte ratio as a predictor of adverse outcomes of acute pancreatitis. Pancreatology. 2001;11:445–452.
- Seretis C, Gourgiotis S, Gemenetzis G, et al. The significanceof neutrophil/lymphocyte ratio as a possible marker of underlying papillary microcarcinomas in thyroidal goiters: a pilot study. Am J Surg. 2013;205:691–696.
- Szkandera J, Absenger G, Liegl-Atzwanger B, et al. Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients. Br J Cancer. 2013;108:1677–1683.
- Fowler AJ, Agha RA. Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography-the growing versatility of NLR. Atherosclerosis. 2013;228:44–45.
- Çakır U, Tuman TC, Yıldırım O. Increased neutrophil/lymphoctye ratio in patients with bipolar disorder: a preliminary study. Psychiatr Danub. 2015;27:180–184.
- Erminio T, Bertoni G. Some physiological and biochemical methods for acute and chronic stress evaluation in dairy cows. Ital J Anim Sci. 2009;8:265–286.
- Semiz M, Yildirim O, Canan F, et al. Elevated neutrophil/lymphocyte ratio in patients with schizophrenia. Psychiatria Danub. 2014;26:220–225.
- First MB, Spitzer RL, Gibbon M. Structed Clinical interview for DSM IV Axis Disorders (SCID-1) Clinical version. Washington (DC); London: American Psychiatric Press; 1997.
- Çorapçıoğlu A, Aydemir Ö, Yıldız M, Köroğlu E. DSM IV Eksen 1 bozuklukları (SCID-1) için yapılandırılmış klinik görüşme, Klinik versiyon. Ankara: Hekimler Yayın Birliği; 1999.
- Heaton RK, Chelune GJ, Talley JL, et al. Wisconsin card sorting test manual: Revised and expanded. Florida: Psycological Assessment Resources; 1993.
- Karakaş S, Eski R, Başar E. Türk kültürü için standardizasyonu yapılmış nöropsikolojik testler topluluğu: BİLNOT Bataryası. 32. Ulusal Nöroloji Kongresi Kitabı. İstanbul Ufuk Matbaası, s. 43–70; 1996.
- Stroop JR. Studies of interference in serial verbal reaction. J Exp Psychol. 1935;18:643–662.
- Spreen O, Strauss E. A compendium of neuropsychological tests: administration, norms, and commentary, 2. baskı. New York: University Press; 1998.
- Karakaş S. Bilişsel fonksiyonların değerlendirilmesinde nöropsikolojik testler. Türk Nöroloji Dergisi 8: 61-9. Karakaş S. BILNOT Bataryası El Kitabı: Nöropsikolojik Testler için Araştırma ve Geliştirme Çalışmaları. Ankara, Dizayn Ofset, 2004.
- Rey A. L’examen clinique en psychologie. Paris: Presse Universitaire de France; 1964.
- Açıkgöz DG. Bellek ve dikkat fonksiyonlarını ölçen nöropsikolojik testler faktör yapısının görgül ve istatistiksel yollardan değerlendirilmesi. Hacettepe Üniversitesi Sosyal Bilimler Enstitüsü, Yüksek Lisans Tezi, Ankara; 1995.
- Balta S, Demirkol S, Celik T, et al. Association between coronary artery ectasia and neutrophil-lymphocyte ratio. Angiology. 2013;64:627–632.
- Ozturk C, Balta S, Balta I, et al. Neutrophil-lymphocyte ratio and carotid-intima media thickness in patients with behcet disease without cardiovascular involvement. Angiology. 2014;66:291–296.
- Fici F, Celik T, Balta S, et al. Comparative effects of nebivolol and metoprolol on red cell distribution width and neutrophil/lymphocyte ratio in patients with newly diagnosed essential hypertension. J Cardiovasc Pharmacol. 2013;62:388–393.
- Özdin S, Sarisoy G, Böke Ö. A comparison of the neutrophil-lymphocyte, platelet-lymphocyte and monocyte-lymphocyteratios in schizophrenia and bipolar disorder patients – a retrospective file review. Nord J Psychiatry. 2017;71:1–4.
- Munkholm K, Weikop P, Kessing LV, et al. Elevated levels of IL-6 and IL-18 in manic and hypomanic states in rapid cycling bipolar disorder patients. Brain Behav Immun. 2015;43:205–213.
- Lotrich FE, Butters MA, Aizenstein H, et al. The relationship between interleukin-1 receptor antagonist and cognitive function in older adults with bipolar disorder. Int J Geriatr Psychiatry. 2014;29:635–644.
- Hamdani N, Daban-Huard C, Lajnef M, et al. Cognitive deterioration among bipolar disorder patients infected by Toxoplasma gondii is correlated to interleukin 6 levels. J Affect Disord. 2015;1(179):161–166.
- Hope S, Hoseth E, Dieset I, et al. Inflammatory markers are associated with general cognitive abilities in schizophrenia and bipolar disorder patients and healthy controls. Schizophr Res. 2015;165:188–194.
- Zhang XY, Tang W, Xiu MH, et al. Interleukin 18 and cognitive impairment in first episode and drug naïve schizophrenia versus healthy controls. Brain Behav Immun. 2013;32:105–111.
- Mori I, Hossain MJ, Takeda K, et al. Impaired microglial activation in the brain of IL-18-gene-disrupted mice after neurovirulent influenza a virus infection. Virology. 2001;28:163–170.
- Schmidt OI, Morganti-Kossmann MC, Heyde CE, et al. Tumor necrosis factor-mediated inhibition of interleukin-18 in the brain: a clinical and experimental study in head-injured patients and in a murine model of closed head injury. J Neuroinflammation. 2004;1:13.